San Diego, CA, United States of America

Yoshihiro Ishihara

This inventor holds 3 USPTO granted patents and 14 published patent applications and 2 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Ishihara. Retrieved from https://idiyas.com/inventor/yoshihiro-ishihara-49ylwjb6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 15.1

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Contributions of Yoshihiro Ishihara to Cystic Fibrosis Treatment

Introduction: Yoshihiro Ishihara is an innovative inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for cystic fibrosis. With a focus on the cystic fibrosis transmembrane conductance regulator (CFTR), his work is noteworthy in the medical community.

Latest Patents: Yoshihiro Ishihara holds a patent for "Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator." This patent outlines modulators of CFTR and includes pharmaceutical compositions containing these modulators. Furthermore, it describes methods of treating cystic fibrosis by administering these modulators and details the processes for their development.

Career Highlights: Ishihara’s career is marked by his role at Vertex Pharmaceuticals, where he continues to contribute to groundbreaking research. His dedication to improving the lives of those affected by cystic fibrosis through innovative pharmaceutical solutions is commendable and represents a significant advancement in therapeutic approaches.

Collaborations: Throughout his career, Yoshihiro has collaborated with esteemed colleagues such as Alexander Russell Abela and Jeremy J. Clemens. These collaborations have enhanced the research and development of effective treatments, demonstrating the power of teamwork in driving medical innovation forward.

Conclusion: Yoshihiro Ishihara’s contributions to the field of cystic fibrosis treatment through his patented work exemplify the impact of dedicated inventors in the scientific community. His affiliation with Vertex Pharmaceuticals and collaborations with fellow researchers further strengthen the pursuit of better healthcare solutions. As innovations continue to unfold, the work of inventors like Ishihara remains vital in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…